** Shares of Trajan Group Holdings TRJ.AX rise 11.5% to A$0.925, eyeing their best trading session since mid-May 2024

** Stock hits highest since February 6

** Life sciences co logs 1H25 adjusted EBITDA of A$7.9 mln ($4.97 mln) vs A$4 mln during the same period last year

** Attributes earnings growth to strong distribution from its capital equipment segment

** Also reaffirms net revenue guidance of A$160 mln-A$165 mln for fiscal 2025 vs A$155 mln in FY24

** More than 66,000 shares change hands, 3.6 times the 30-day avg

** Traja down 18.1% YTD, including current session's moves

($1 = 1.5908 Australian dollars)

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))